Overview

Ph1 Lobeline Interaction Study - 1

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if there are significant cardiovascular or other interactions between sublingual lobeline and intravenous methamphetamine.

Phase:

Phase 1

Details

Lead Sponsor:

National Institute on Drug Abuse (NIDA)

Treatments:

Lobeline